Intelligent Bio Solutions (INBS) Current Assets (2020 - 2025)

Intelligent Bio Solutions has reported Current Assets for 6 years, with the latest figure at $4.1 million in Q2 2025.

• For the quarter ending Q2 2025, Current Assets fell 51.51% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2025 stood at $4.1 million (down 51.51% YoY), and the FY2025 full-year result was $4.1 million, down 51.51% from the prior year.
• Current Assets for Q2 2025 stood at $4.1 million, down from $5.1 million in the prior quarter.
• The five-year high for Current Assets was $18.2 million in Q2 2021, with the low at $2.7 million in Q3 2023.
• Average Current Assets over 5 years is $8.7 million, with a median of $7.3 million recorded in 2022.
• Year-over-year, Current Assets soared 678.1% in 2021 and slumped 67.2% in 2023.
• Tracing INBS's Current Assets over 5 years: stood at $14.1 million in 2021, then tumbled by 54.72% to $6.4 million in 2022, then tumbled by 53.83% to $2.9 million in 2023, then jumped by 37.93% to $4.1 million in 2024, then rose by 1.9% to $4.1 million in 2025.
• The last three Current Assets figures came in at $4.1 million (Q2 2025), $5.1 million (Q1 2025), and $4.1 million (Q4 2024), per Business Quant data.

Peer Comparison